PortfoliosLab logoPortfoliosLab logo
AURA vs. VOO
Performance
Return for Risk
Dividends
Drawdowns
Volatility

Performance

AURA vs. VOO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Aura Biosciences, Inc. (AURA) and Vanguard S&P 500 ETF (VOO). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

AURA vs. VOO - Yearly Performance Comparison


2026 (YTD)20252024202320222021
AURA
Aura Biosciences, Inc.
22.94%-33.70%-7.22%-15.62%-38.16%14.73%
VOO
Vanguard S&P 500 ETF
-3.66%17.82%24.98%26.32%-18.17%3.79%

Returns By Period

In the year-to-date period, AURA achieves a 22.94% return, which is significantly higher than VOO's -3.66% return.


AURA

1D
0.15%
1M
9.12%
YTD
22.94%
6M
8.94%
1Y
18.17%
3Y*
-10.29%
5Y*
10Y*

VOO

1D
0.79%
1M
-4.29%
YTD
-3.66%
6M
-1.41%
1Y
18.17%
3Y*
18.58%
5Y*
11.93%
10Y*
14.14%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Aura Biosciences, Inc.

Vanguard S&P 500 ETF

Return for Risk

AURA vs. VOO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AURA
AURA Risk / Return Rank: 5050
Overall Rank
AURA Sharpe Ratio Rank: 5151
Sharpe Ratio Rank
AURA Sortino Ratio Rank: 5252
Sortino Ratio Rank
AURA Omega Ratio Rank: 4848
Omega Ratio Rank
AURA Calmar Ratio Rank: 5151
Calmar Ratio Rank
AURA Martin Ratio Rank: 5050
Martin Ratio Rank

VOO
VOO Risk / Return Rank: 6060
Overall Rank
VOO Sharpe Ratio Rank: 5454
Sharpe Ratio Rank
VOO Sortino Ratio Rank: 5757
Sortino Ratio Rank
VOO Omega Ratio Rank: 6161
Omega Ratio Rank
VOO Calmar Ratio Rank: 5959
Calmar Ratio Rank
VOO Martin Ratio Rank: 6969
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AURA vs. VOO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Aura Biosciences, Inc. (AURA) and Vanguard S&P 500 ETF (VOO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


AURAVOODifference

Sharpe ratio

Return per unit of total volatility

0.30

1.01

-0.71

Sortino ratio

Return per unit of downside risk

0.90

1.53

-0.63

Omega ratio

Gain probability vs. loss probability

1.10

1.23

-0.13

Calmar ratio

Return relative to maximum drawdown

0.46

1.55

-1.09

Martin ratio

Return relative to average drawdown

0.92

7.31

-6.39

AURA vs. VOO - Sharpe Ratio Comparison

The current AURA Sharpe Ratio is 0.30, which is lower than the VOO Sharpe Ratio of 1.01. The chart below compares the historical Sharpe Ratios of AURA and VOO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


AURAVOODifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.30

1.01

-0.71

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.71

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.79

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.24

0.83

-1.07

Correlation

The correlation between AURA and VOO is 0.35, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

AURA vs. VOO - Dividend Comparison

AURA has not paid dividends to shareholders, while VOO's dividend yield for the trailing twelve months is around 1.18%.


TTM20252024202320222021202020192018201720162015
AURA
Aura Biosciences, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
VOO
Vanguard S&P 500 ETF
1.18%1.13%1.24%1.46%1.69%1.25%1.54%1.88%2.06%1.78%2.02%2.10%

Drawdowns

AURA vs. VOO - Drawdown Comparison

The maximum AURA drawdown since its inception was -80.31%, which is greater than VOO's maximum drawdown of -33.99%. Use the drawdown chart below to compare losses from any high point for AURA and VOO.


Loading graphics...

Drawdown Indicators


AURAVOODifference

Max Drawdown

Largest peak-to-trough decline

-80.31%

-33.99%

-46.32%

Max Drawdown (1Y)

Largest decline over 1 year

-31.26%

-11.98%

-19.28%

Max Drawdown (5Y)

Largest decline over 5 years

-24.52%

Max Drawdown (10Y)

Largest decline over 10 years

-33.99%

Current Drawdown

Current decline from peak

-73.08%

-5.55%

-67.53%

Average Drawdown

Average peak-to-trough decline

-58.57%

-3.72%

-54.85%

Ulcer Index

Depth and duration of drawdowns from previous peaks

15.62%

2.55%

+13.07%

Volatility

AURA vs. VOO - Volatility Comparison

Aura Biosciences, Inc. (AURA) has a higher volatility of 19.01% compared to Vanguard S&P 500 ETF (VOO) at 5.34%. This indicates that AURA's price experiences larger fluctuations and is considered to be riskier than VOO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


AURAVOODifference

Volatility (1M)

Calculated over the trailing 1-month period

19.01%

5.34%

+13.67%

Volatility (6M)

Calculated over the trailing 6-month period

40.09%

9.47%

+30.62%

Volatility (1Y)

Calculated over the trailing 1-year period

61.29%

18.11%

+43.18%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

69.88%

16.82%

+53.06%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

69.88%

17.99%

+51.89%